The Senate bill to place caps on Medicare prescription costs got lots of attention last week. The bill could lead to $2,000 per capita ceilings on cumulative Parts B and D drug costs and permit Medicare to negotiate drug prices with pharmaceutical companies, although on a modest basis. If enacted in its present form, the caps would take effect in 2025. …
Keep reading with a 7-day free trial
Subscribe to Aging in America to keep reading this post and get 7 days of free access to the full post archives.